Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Sep;170(1):17-23.
doi: 10.1016/j.jss.2011.02.018. Epub 2011 Mar 12.

Differentiating passive from transporter-mediated uptake by PepT1: a comparison and evaluation of four methods

Affiliations
Comparative Study

Differentiating passive from transporter-mediated uptake by PepT1: a comparison and evaluation of four methods

Jeffrey S Scow et al. J Surg Res. 2011 Sep.

Abstract

Background: To quantify transmembrane transport of dipeptides by PepT1, passive uptake (non-PepT1 mediated) must be subtracted from total (measured) uptake. Three methods have been described to estimate passive uptake: perform experiments at cold temperatures, inhibit target dipeptide uptake with a greater concentration of a second dipeptide, or use modified Michaelis-Menten kinetics. We hypothesized that performing uptake experiments at pH 8.0 would estimate passive uptake accurately, because PepT1 requires a proton gradient. Our aim was to determine the most accurate method to estimate passive uptake.

Methods: Caco-2 cells were incubated with various concentrations of glycyl-sarcosine (gly-sar) at pH 6.0 and at 37°C to measure total uptake. Passive uptake was estimated: (1) by incubating Caco-2 cells with varying concentrations of gly-sar at 4°C, (2) in the presence of 50 mM glycyl-leucine, (3) in solution at pH 8.0, or (4) using modified Michaelis-Menten kinetics. PepT1-mediated uptake was calculated by subtracting passive uptake from total uptake. K(m), V(max), and % gly-sar transported by PepT1 were calculated and compared.

Results: K(m), V(max), and % gly-sar transported by PepT1 varied from 0.7 to 2.4 mM, 8.4 to 21.0 nmol/mg protein/10 min, and 69% to 87%, respectively. Uptakes calculated with cold, 50 mM gly-leu and using modified Michaelis-Menten kinetics were similar but differed significantly from uptake at pH 8.0 (P < 0.001).

Conclusions: Estimating passive uptake at pH 8.0 does not appear to be accurate. Measuring uptake at cold temperatures or in the presence of a greater concentration of a second dipeptide, and confirming results with modified Michaelis-Menten kinetics is recommended.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Total and passive uptake (pH 8.0, 50 mM gly-leu, and 4 °C) of gly-sar into Caco-2 cells. Uptake values are presented as mean ± the standard error of the mean (n=9).
Figure 2
Figure 2
PepT1-mediated uptake of gly-sar into Caco-2 cells. Uptake values are presented as mean ± the standard error of the mean (n=9). MMM is Modified Michaelis-Menten Equation
Figure 3
Figure 3
Graphic representation of the passive and active components of absorption using the modified Michaelis-Menten equation (eq 2). Uptake values are presented as mean ± the standard error of the mean (n=9).

References

    1. Bhardwaj RK, Herrera-Ruiz D, Sinko PJ, Gudmundsson OS, Knipp G. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells. J Pharmacol Exp Ther. 2005;314:1093–1100. - PubMed
    1. Brandsch M, Miyamoto Y, Ganapathy V, Leibach FH. Expression and protein kinase C-dependent regulation of peptide/H+ co-transport system in the Caco-2 human colon carcinoma cell line. Biochem J. 1994;299(Pt 1):253–260. - PMC - PubMed
    1. D’Souza VM, Buckley DJ, Buckley AR, Pauletti GM. Extracellular glucose concentration alters functional activity of the intestinal oligopeptide transporter (PepT-1) in Caco-2 cells. J Pharm Sci. 2003;92:594–603. - PubMed
    1. Herrera-Ruiz D, Faria TN, Bhardwaj RK, Timoszyk J, Gudmundsson OS, Moench P, Wall DA, Smith RL, Knipp GT. A novel hPepT1 stably transfected cell line: establishing a correlation between expression and function. Mol Pharm. 2004;1:136–144. - PubMed
    1. Chu C, Okamoto CT, Hamm-Alvarez SF, Lee VH. Stable transfection of MDCK cells with epitope-tagged human PepT1. Pharm Res. 2004;21:1970–1973. - PubMed

Publication types